The new asthma treatment that could ‘transform lives’

A monthly injection could enable severe asthma patients to stop taking daily steroid tablets without affecting their symptoms, a new trial has found.

The drug, Tezepelumab (also known as Tezspir and made by AstraZeneca), works by binding to and blocking a protein that drives airway inflammation.

The injection is recommended as an additional maintenance treatment for patients over 12 when usual medications have not proven effective enough.

It was approved for NHS use by the National Institute for Health and Care Excellence (NICE) in 2023.

Read full article.

Source: The Independent, 27 November 2025.